European Psychiatry - Volume 33 - March 2016

668 / 812

S664 24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805
symptoms took place. Careful reconstruction of the clinical history
showed no stressors or drug consumption. And immediately pre-
vious 5-day phase of insomnia, hyperactivity and expenditure was
described by the patient’s wife.
Discussion Three inpatient admissions, a careful clinical history
and a thorough review of the evidence regarding Perris criteria led
to a diagnosis of CP.
Conclusion CP, a classical nosological approach, is helpful in a
clinical setting, as it might imply different prognosis and treatment.
Recognition of CP, not included as an entity by the major diagnostic
systems, requires a high index of suspicion.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV985
Cryptococcal meningitis in acute
onset psychosis: A case-study
P. Michielsen ∗, M. Arts
1 Mental Health Western Northern Brabant, Halsteren, Netherlands
2 University Medical Center Groningen, Old Age Psychiatry,
Groningen, Netherlands
∗ Corresponding author.
Introduction Cryptococcal meningitis is a frequently observed
opportunistic infection in patients with late-stage HIV-infection,
especially among people living in South-East Asia and Central
Africa. The worldwide incidence is estimated at one million cases.
The worldwide mortality of HIV-associated cryptococcal menin-
gitis remains high (10–30%), due to the inadequacy of antifungal
treatments and complications of increased intracranial pressure.
Clinical symptoms of cryptococcal meningitis are fever, headache,
vomiting, and altered mental status. Neck stiffness, papiledema,
and focal neurological symptoms are sometimes present.
Objectives We describe the case of a patient who first developed
a delirium, and a few months later an acute-onset psychosis, after
a past cryptococcal infection.
Aims To report a case-study describing acute-onset psychosis as
a neuropsychiatric consequence of HIV-infection.
Methods A case-study is presented and discussed, followed by a
literature review.
Results A 49-year-old African-born male was admitted to hospi-
tal with an acute psychosis. He had been treated by an internist
after being found to have HIV. As a result of non-compliance over a
period of about four months, his cd4-count had dropped to 40. Six
months earlier he had developed cryptococcal meningitis, which
left him a number of neurological and psychiatric symptoms. Dur-
ing his stay in hospital, there had to be good collaboration with the
specialist in internal medicine whose dual task was to manage the
patient’s dramatically low cd4-count as well as his psychosis.
Conclusion Cryptococcal meningitis is a risk factor for psychiatric
disorders and mortality in HIV-infected persons.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV986
“Bouffée délirante” induced by
meditation
R.A. Baena Mures ∗, L. Niell Galmes , Y. Lázaro Pascual ,
M.D. Saiz Gonzalez
1 Hospital Clinico San Carlos, Psychyatry, Madrid, Spain
2 Hospital Clinico San Carlos, Psychiatry, Madrid, Spain
∗ Corresponding author.
Introduction Meditation is frequently applied in Western as well
as non-Western countries for different purposes; we know little
about adverse events. The symptomatology of ameditation-related
psychosis appears to show similarities with that we call “bouffée
delirante”.
Methods A female patient is described who developed an acute
and transient psychosis with polymorphic symptomatology after
meditating (Bikram-yoga). We made a literature search for psy-
chotic states related to meditation.
Results There are some case reports of psychosis disorder
induced by meditation. Some cultural syndromes like Qi-gong
appear on DSM-IV as psychotic reaction. In this case, the syndrome
is not culture bound.
Conclusions Meditation can act as a stressor in vulnerable
patients who may develop a transient psychosis with polymorphic
symptomatology (confusion, pananxiety, mood swings and mood
dystonic psychotic symptoms) with a short duration.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV987
Erotomania – A review of De
Clérambault’s syndrome
C. Oliveira ∗, S. Alves , C. Ferreira , C. Agostinho , M.J. Avelino
Centro Hospitalar Psiquiátrico de Lisboa, SETA, Lisbon, Portugal
∗ Corresponding author.
Introduction Erotomania (also known as De Clerambault’s syn-
drome) is usually described as a rare delusional syndrome
characteristically involving an individual who believes that another
person, typically of higher social, economic or political status, is
in love with the individual. De Clerambault’s syndrome remains a
ubiquitous nosological psychiatric entity with uncertain prognosis
that remains recognised as a subtype of delusional disorder in DSM
5.
Objectives and aims To review the history of Erotomania as a
nosological psychiatric entity, its clinical characteristics and course.
Also to report some selected clinical cases.
Methods The authors have conducted an online search on
PubMed with MeSH words“erotomania”, “erotomaniac delusion”
and “Clerambault” and systematically reviewed some case reports.
Results Erotomania is a relatively uncommon andmisunderstood
disorder characterised by the presence of a persistent erotic delu-
sion. The individual (usually described as a woman) has had little or
no contact with the other personwho is perceived aswatching over,
protecting or following the individual. Despite various authors have
described and named this syndrome, it was Clérambault who first
classed the symptoms into the disorder he referred to as “psychose
Passionelli” (1942). There are numerous theories as to the aetiol-
ogy of this illness that is not uniquely associated with any specific
disorder. We reviewed some clinical cases.
Conclusions Erotomania is a relatively uncommon psychiatric
disorder. An increased awareness and understanding of this illness
will assist in the recognition of patients affected, opening doors for
future progress on its aetiology and, therefore, the development of
new treatment options.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV988
ADHD-associated risk-taking: The role
of benefit and risk perceptions
Y. Pollak ∗, H. Aloni , R. Shoham
1 Hebrew University, School of Education, Jerusalem, Israel
2 Hebrew University, Psychology, Jerusalem, Israel
3 Talpiot College, Special Education, Holon, Israel
∗ Corresponding author.